| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.
|
Eur J Cancer
|
2007
|
1.06
|
|
2
|
The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.
|
Histochem Cell Biol
|
2009
|
0.98
|
|
3
|
National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?
|
Eur J Public Health
|
2013
|
0.95
|
|
4
|
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
|
AIDS
|
2013
|
0.93
|
|
5
|
Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid.
|
Eur J Obstet Gynecol Reprod Biol
|
2009
|
0.87
|
|
6
|
Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth.
|
Arch Gynecol Obstet
|
2012
|
0.86
|
|
7
|
Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases.
|
AIDS
|
2014
|
0.86
|
|
8
|
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells.
|
Biochem Biophys Res Commun
|
2008
|
0.83
|
|
9
|
Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
|
Eur J Cancer
|
2009
|
0.82
|
|
10
|
Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
|
Oncol Rep
|
2007
|
0.82
|
|
11
|
Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid.
|
BMC Res Notes
|
2012
|
0.81
|
|
12
|
The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization.
|
Mol Cancer
|
2010
|
0.81
|
|
13
|
HIV testing in pregnancy: are we testing enough?
|
Arch Gynecol Obstet
|
2010
|
0.80
|
|
14
|
New prospects for nelfinavir in non-HIV-related diseases.
|
Curr Mol Pharmacol
|
2010
|
0.80
|
|
15
|
Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib.
|
Invest New Drugs
|
2009
|
0.80
|
|
16
|
German-Austrian recommendations for HIV-therapy in pregnancy: update May 2003.
|
Eur J Med Res
|
2004
|
0.79
|
|
17
|
German-Austrian recommendations for HIV-therapy in pregnancy--common declaration of The German AIDS-society (DAIG), The Austrian AIDS-society (OEAG) as well as The Robert-Koch Institute Berlin (RKI), The German Association of Physicians specialized in HIV Care (DAGNAE), The German Society of Pediatric and Youth Medicine (DGKJ), The German AIDS Pediatric Association (PAAD), The German Society of Obstetrics and Gynecology (DGGG), The National Reference Center for Retroviruses (NRZ), German AIDS Assistance (DAH).
|
Eur J Med Res
|
2002
|
0.78
|
|
18
|
German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.
|
Eur J Med Res
|
2009
|
0.78
|
|
19
|
The HIV reverse transcriptase inhibitor tenofovir induces cell cycle arrest in human cancer cells.
|
Invest New Drugs
|
2011
|
0.78
|
|
20
|
Development and characterisation of an antibody for the immunohistochemical detection of inhibin/activin betaE (betaE) in normal human ovarian and placental tissue.
|
Acta Histochem
|
2009
|
0.76
|
|
21
|
Immunohistochemical labeling of the inhibin/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines.
|
J Histochem Cytochem
|
2010
|
0.76
|
|
22
|
Atazanavir exposure is effective during pregnancy regardless of tenofovir use.
|
Antivir Ther
|
2014
|
0.75
|
|
23
|
The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
|
Anticancer Res
|
2007
|
0.75
|
|
24
|
Congenital cytomegalovirus infection in pregnancy: a case report of fetal death in a CMV-infected woman.
|
Arch Gynecol Obstet
|
2007
|
0.75
|
|
25
|
[Pregnant with HIV infection: the risk for the child is minimal].
|
MMW Fortschr Med
|
2010
|
0.75
|